Additional Information
Market: AIM
Sector: Pharmaceuticals
EPIC: RENE
Latest Price: 3.40  (0.74% Ascending)
52-week High: 6.16
52-week Low: 3.25
Market Cap: 26.34M
1 year chart
1 day chart

ReNeuron is a leading, clinical-stage stem cell business.  Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.